Evidence map›Paper›PMID 41415286›Full record

ReviewFrontiers in immunology2025

Dual role of complement in neuronal repair.

Agnieszka Lukomska, Peter Ciesielski, Mariusz Z Ratajczak, Magdalena Kucia

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Agnieszka LukomskaDepartment of Regenerative Medicine, Center for Preclinical Studies and Technology, Medical University of Warsaw, Warsaw, Poland.
Peter CiesielskiDepartment of Regenerative Medicine, Center for Preclinical Studies and Technology, Medical University of Warsaw, Warsaw, Poland.
Mariusz Z RatajczakDepartment of Regenerative Medicine, Center for Preclinical Studies and Technology, Medical University of Warsaw, Warsaw, Poland.
Magdalena KuciaDepartment of Regenerative Medicine, Center for Preclinical Studies and Technology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complement system, long regarded as an arm of innate immunity, is now recognized as an important modulator of nervous system pathophysiology. Following acute injury or in chronic neurodegenerative diseases, promoting neuronal survival and axon regeneration remains a formidable clinical challenge. This review synthesizes the extensive, paradoxical evidence of complement's dual role in neurodegeneration and repair. We examine how complement activation is both detrimental-driving neuroinflammation, apoptosis, and pathological autophagy via receptors like C5aR1 and its interaction with the NLRP3 inflammasome-and beneficial, promoting C5a-mediated phagocyte recruitment for debris clearance and C3-dependent synaptic stripping for circuit remodeling. This review's unique contribution is its integration of these classic extracellular pathways with the recently discovered intracellular complement system, or 'complosome.' We explore how the complosome offers a novel mechanistic framework linking complement to fundamental cellular processes, including metabolism and survival, particularly through its intricate connection with the master regenerative mTOR pathway. This highlights complement not as a simple inflammatory switch, but as a sophisticated signaling network. Understanding this duality is essential for developing therapies that selectively suppress complement-driven damage while enhancing its regenerative functions.

Indexed as

Complement System ProteinsNerve RegenerationNeurodegenerative DiseasesNeuronsAnimalsAutophagyComplement ActivationHumansInflammasomesSignal TransductionComplement System ProteinsInflammasomesaxon regenerationC3aRC5aRcomplosomemTORNLRP3

Identifiers

PMID41415286
PMCPMC12708253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.